Diadema Partners »

Structure Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 192k 69.55

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Structure Therapeutics

venBio Select Advisor
Wellington Management Company
FMR
Henderson Group
Deep Track Capital
BVF
Baker Bros. Advisors
RA Capital Management
Principal Financial Group
Millennium Management
Ameriprise Financial
Casdin Capital
OrbiMed Advisors
Siren
TCG Crossover Management

View all funds holding Structure Therapeutics